JW Pharmaceutical
JW Pharmaceutical
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PROGAIN Trial in Gastric Cancer Surgery | Digestive System Diseases, Digestive System Neoplasms, Hyperphagia, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 3 | 2026-05-19 | NCT07488611 | |
| to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibroid Uterus, Genital Diseases, Hemorrhage, Menorrhagia, Menstruation Disturbances, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Uterine Hemorrhage, female reproductive system disorder, leiomyoma, myomatous neoplasm, neoplasm, uterine disorder | Recruiting | Phase 3 | 2026-05-01 | NCT07378098 | |
| To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers | Healthy | Recruiting | Phase 1 | 2026-04-23 | NCT07514780 | |
| Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study | Dyslipidemias, Insulin Resistance, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Recruiting | Not stated | 2026-04-13 | NCT07523971 | |
| Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Active, not recruiting | Phase 4 | 2026-03-02 | NCT07442630 | |
| Glycemic Variability of Combination Therapies in T2DM | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-03-02 | NCT07442006 | |
| Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, cardiovascular disorder, hypertensive disorder, metabolic disease, vascular disorder | Recruiting | Phase 3 | 2025-09-09 | NCT06643130 | |
| To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers | Healthy | Recruiting | Phase 1 | 2025-01-13 | NCT06703710 | |
| Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 3 | 2024-12-27 | NCT02843191 |